Product Images Carvedilol

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Carvedilol NDC 68462-163 by Glenmark Pharmaceuticals Inc., Usa, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

LBL12.5mg100

LBL12.5mg100

LBL3.125mg100

LBL3.125mg100

LBL6.25mg100

LBL6.25mg100

carvedilol 25mg 100tab

carvedilol 25mg 100tab

figure-1 - figure 1

figure-1 - figure 1

This is a not-available description as the provided text contains only a few numerical characters and medication names without any context or information.*

figure-2 - figure 2

figure-2 - figure 2

figure-3 - figure 3

figure-3 - figure 3

The text describes a figure labeled as "Survival Analysis for CAPRICORN (intent-to-treat)." The figure consists of a line graph plotting time (up to 24 units) on the x-axis against the percentage of mortality on the y-axis. There are two lines on the graph: one labeled "Placebo" that begins at 30% mortality and ends at approximately 60% mortality, and one labeled "Carvedilol" that begins at 28% mortality and ends at approximately 45% mortality. The figure also includes labels on the x-axis at 3-month intervals. The P-value for the comparison between the two groups is 0.03.*

figure-4 - figure 4

figure-4 - figure 4

The text appears to be a table or a figure with subgroups and their corresponding effects on mortality for CAPRICORN. It is not possible to generate a useful description without visual information on the table/figure.*

structure

structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.